OTCMKTS:GTSIF Lobe Sciences (GTSIF) Stock Price, News & Analysis $0.03 0.00 (-0.60%) As of 10/15/2026 Add Compare Share Share Stock Analysis Stock AnalysisChart About Lobe Sciences Stock (OTCMKTS:GTSIF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Lobe Sciences alerts:Sign Up Key Stats Today's Range$0.03▼$0.0450-Day Range$0.03▼$0.0652-Week Range$0.03▼$0.22Volume45,068 shsAverage Volume595,549 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Lobe Sciences Ltd. is a life sciences company focused on developing psychedelic-derived medicines and related drug-delivery technologies. Its research has centered on potential treatments for neurological and mental health conditions, including migraine and cluster headache disorders, as well as other conditions involving the central nervous system. The company has investigated psilocybin-based therapeutic candidates and alternative delivery methods intended to improve the administration, consistency, and potential clinical use of psychedelic medicines. Its development activities have included preclinical research, formulation work, and efforts to advance selected candidates toward clinical evaluation. Lobe Sciences is based in Canada and has pursued development and research activities intended for international pharmaceutical and healthcare markets. The company’s programs and corporate strategy may change as research progresses; detailed, current information about its leadership and commercial operations is not reliably available from the information provided.AI Generated. May Contain Errors. Read More Receive GTSIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lobe Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GTSIF Stock News HeadlinesLobe Sciences Raises $2.1 Million to Advance Sickle Cell Drug Toward Clinical TrialsAugust 20, 2026 | tipranks.comLOBEF Lobe Sciences Ltd.January 2, 2026 | seekingalpha.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.October 16 at 1:00 AM | Weiss Ratings (Ad)Lobe Sciences Strengthens Financial Position with Debt SettlementOctober 23, 2025 | tipranks.comLobe Sciences Strengthens Financial Position with Debt SettlementOctober 23, 2025 | tipranks.comLobe Sciences Strengthens Balance Sheet with Strategic Debt SettlementOctober 9, 2025 | tipranks.comLobe Sciences to Present New Therapy for Cluster Headaches at 2025 ConferenceSeptember 9, 2025 | tipranks.comLobe Sciences Strengthens Board with New AppointmentSeptember 8, 2025 | tipranks.comSee More Headlines GTSIF Stock Analysis - Frequently Asked Questions How have GTSIF shares performed this year? Lobe Sciences' stock was trading at $0.0340 at the start of the year. Since then, GTSIF stock has decreased by 2.4% and is now trading at $0.0331. How do I buy shares of Lobe Sciences? Shares of GTSIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Lobe Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lobe Sciences investors own include Aurora Cannabis (ACB), Intel (INTC), Riot Platforms (RIOT), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF) and Nokia (NOK). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:GTSIF CIKN/A Webwww.greenstarbiosciences.com Phone604-834-9499FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (OTCMKTS:GTSIF) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lobe Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lobe Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
